转录因子与肿瘤进展的研究现状
Current Status of Research on Transcription Factor and Tumor Progression
摘要: 随着医学研究的深入，转录因子作为一种重要的细胞内调节蛋白，在肿瘤生成与发展中的作用越来越受到关注。本综述基于前期工作18篇文章，涵盖肿瘤标志物与预后分析、细胞功能、蛋白质相互作用与细胞生物学以及基因表达与调控机制四个方面，系统地总结了转录因子在肿瘤进展中的研究现状及其作用机制。其中，ERCC1与非小细胞肺癌关系的研究强调了其在肺鳞癌预后上的潜在标志物角色。信号通路方面的研究揭示了转录因子在细胞增殖、分化及肿瘤进程中的重要作用。对TRIB2、TDP-43及其他分子的研究揭示了它们之间的相互作用，可能影响肿瘤细胞的幸存与增殖。同时，抑癌基因PDCD5、lncRNAs等在基因表达调控中起到关键调节作用，为理解肿瘤生成的分子机制提供了新的视角。本综述从分子角度为开发新的癌症治疗靶点提供了可能的方向，为临床治疗提供了理论基础。
Abstract: With the deepening of medical research, the role of transcription factors as an important intracellular regulatory protein in tumor generation and development has attracted increasing attention. Based on 18 articles from previous work, covering four aspects: tumor markers and prognosis analysis, signaling pathway and cell function, protein interaction and cell biology, and gene expression and regulation mechanism, this review systematically summarizes the research status and action mechanism of transcription factors in tumor progression. Among them, the relationship of ERCC1 with non-small cell lung cancer highlights its potential marker role in the prognosis of lung squamous cell carcinoma. Studies on signaling pathways have revealed the important roles of JNK pathway and Wnt/β-catenin pathway in cell proliferation, differentiation and tumor progression. Studies of TRIB2, TDP-43, and other molecules have revealed the interactions between them that may affect the survival and proliferation of tumor cells. Meanwhile, the tumor suppressor genes PDCD5 and lncRNAs play key regulatory roles in the regulation of gene expression, providing a new perspective for understanding the molecular mechanism of tumor generation. This review provides possible directions for developing new targets for cancer therapy from a molecular perspective and provides a theoretical basis for clinical treatment.
文章引用：张建, 李晓勇. 转录因子与肿瘤进展的研究现状[J]. 临床医学进展, 2024, 14(5): 980-989. https://doi.org/10.12677/acm.2024.1451515

参考文献

[1] 莫春生, 罗学平, 洪强, 陈健智. ERCC1在肺鳞癌原发灶及淋巴结转移灶中的表达及其预后意义[J]. 医学美学美容(中旬刊), 2015, 24(6): 108-109.
[2] 周师师, 马锐. ERCC1及其多态性与非小细胞肺癌关系的研究现状[J]. 医学与哲学, 2015, 36(14): 74-77.
[3] 周慧蕾. CCNB1和CCNA2在人类正常邻近组织和肺癌中不同功能激活及抑制转换机制与网络构建[D]: [硕士学位论文]. 北京: 北京邮电大学, 2015.
[4] 严文君. CBX7和EZH2在乳腺癌中的表达及其临床意义[D]: [博士学位论文]. 郑州: 郑州大学, 2015.
[5] Treat, A.C. (2015) The Role of NHERF1/EBP50 in WNT Signaling in the Epithelium. Ph.D. Thesis, University of Pittsburgh, Pittsburgh.
[6] 郝玉秋. RBM5-Wnt/β-catenin信号通路在香烟烟雾致肺泡上皮细胞损伤中的作用机制[D]: [硕士学位论文]. 长春: 吉林大学, 2015.
[7] 罗红, 黄贵华, 林华胜. PTEN、Bcl-2与慢性萎缩性胃炎相关性研究进展[J]. 湖南中医杂志, 2015, 31(11): 187-189.
[8] 陆琼, 马玲. JNK信号通路胞外生长因子途径在肝再生中作用研究[J]. 中外食品工业(下半月), 2015(1): 67, 69.
[9] Hughes Hallett, J. (2015) Systems Level Analysis of TORC1 Pathway Signaling in S. cerevisiae. Ph.D. Thesis, University of Arizona, Tucson.
[10] Qian, L. (2015) Grb7 and Hax1 May Colocalize to Mitochondria in SKBR3 Cells and Affect Caspase3 Cleavage of Hax1. Ph.D. Thesis, New Mexico State University, Las Cruces.
[11] Layne Black, J. (2015) Exploration of the Role of CIB1 in Cell Survival and Tumor Growth. Ph.D. Thesis, University of North Carolina at Chapel Hill, Chapel Hill.
[12] Sundaram, K. (2015) Expression and Function of Human IkappaBzeta (IκBζ) in Lung Inflammation. Ph.D. Thesis, Ohio State University, Columbus.
[13] 王雷. 抑癌基因PDCD5在脑神经胶质瘤中的表达及其对化疗药物敏感性影响研究[D]: [博士学位论文]. 长春: 吉林大学, 2015.
[14] Acevedo, J. (2015) Biochemical Mechanism of TopBP1 Recruitment to Sites of DNA Damage. Ph.D. Thesis, University of Southern California, Los Angeles.
[15] da Silva, S.V.G. (2015) Epigenetics and Alternative Splicing. Master’s Thesis, University of Algarve, Faro.
[16] da Silva, N.P.G. (2015) TRIB2 Confers Resistance to MAPK and TOR1 Inhibitors. Master’s Thesis, University of Algarve, Faro.
[17] 扎西英派, 张涛杰, 霍生东, 魏锁成, 阿依木古丽. 葡萄糖调节蛋白GRP78研究进展[J]. 西北民族大学学报(自然科学版), 2015, 36(1): 48-52, 58.
[18] 刘振腾. 长链非编码RNA CTBP1-AS和SRA在多囊卵巢综合征患者中的表达及其相关性研究[D]: [硕士学位论文]. 青岛: 青岛大学, 2015.

为你推荐